Vericel Corporation (VCEL) Stock Price, Quote & News

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 588 5555

Fax: 617 588 5554

Website: www.vcel.com

Address:

64 Sidney Street, Cambridge, United States

Doozio Feb. 21 at 6:41 PM

$VCEL 🐒🍌🧠⏰♾️

0 · Reply

SuperGreenToday Feb. 19 at 6:33 PM

$VCEL Share Price: $38.15 Contract Selected: Jul 17, 2026 $40 Calls Buy Zone: $1.70 – $2.10 Target Zone: $2.87 – $3.51 Potential Upside: 60% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Groyper69 Feb. 14 at 4:24 AM

$VCEL 👀🤯

0 · Reply

Pro_From_Dover Feb. 12 at 3:04 PM

$VCEL worst stock on a major index. these management fools got nuthin for investors.

0 · Reply

copperhat Feb. 11 at 2:59 PM

$VCEL wtf???

0 · Reply

Pro_From_Dover Feb. 9 at 3:18 PM

$VCEL POS

0 · Reply

copperhat Feb. 9 at 3:02 PM

$VCEL degenerate shit

0 · Reply

copperhat Feb. 6 at 1:43 PM

$VCEL seriously, down $1.50 premarket?

0 · Reply

Pro_From_Dover Feb. 5 at 8:21 PM

$VCEL another day of rockin it, I see.

0 · Reply

copperhat Feb. 5 at 6:52 PM

$VCEL seriously, wtf?

0 · Reply

Madison Small Cap Fund Q4 2025: Buys, Sells, And Standouts

AAON AMPL CCOI CFLT CIEN GTLB IBM

Jan 15, 2026, 10:31 AM EST - 5 weeks ago

These under-the-radar stocks combine fast growth with big upside potential

AGYS ASTH BBT CORT CTRE DCOM DOCN

Jan 14, 2026, 5:05 PM EST - 5 weeks ago

Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 9:00 AM EST - 5 weeks ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Jan 6, 2026, 8:30 AM EST - 6 weeks ago

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Nov 14, 2025, 8:30 AM EST - 3 months ago

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Nov 6, 2025, 2:46 PM EST - 3 months ago

Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:55 AM EST - 3 months ago

Vericel Reports Third Quarter 2025 Financial Results

Aug 28, 2025, 8:30 AM EDT - 6 months ago

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Jul 31, 2025, 3:10 PM EDT - 7 months ago

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 8:08 AM EDT - 7 months ago

Vericel Reports Second Quarter 2025 Financial Results

Jul 17, 2025, 8:30 AM EDT - 7 months ago

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Jun 12, 2025, 10:23 AM EDT - 9 months ago

Vericel Corporation: Moving From Sell To Neutral

Jun 10, 2025, 8:30 AM EDT - 9 months ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

May 8, 2025, 1:52 PM EDT - 10 months ago

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 7:55 AM EDT - 10 months ago

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

May 7, 2025, 8:30 AM EDT - 10 months ago

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Apr 24, 2025, 8:30 AM EDT - 10 months ago

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Mar 5, 2025, 11:56 PM EST - 1 year ago

Vericel: Scalable Growth With Strong Margins

Mar 4, 2025, 8:30 AM EST - 1 year ago

Vericel to Present at Multiple Upcoming Investor Conferences

Feb 27, 2025, 1:05 PM EST - 1 year ago

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 7:54 AM EST - 1 year ago

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:30 AM EST - 1 year ago

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 15, 2025, 8:52 AM EST - 1 year ago

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

APLD CVGW

Jan 14, 2025, 4:05 PM EST - 1 year ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Dec 19, 2024, 12:50 PM EST - 1 year ago

Vericel Corporation: Hard To Justify Current Valuation

Nov 7, 2024, 1:52 PM EST - 1 year ago

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2024 Financial Results

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Aug 29, 2024, 9:17 AM EDT - 1 year ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 26, 2024, 7:45 AM EDT - 1 year ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 15, 2024, 4:05 PM EDT - 1 year ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 7, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 1, 2024, 3:58 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports Second Quarter 2024 Financial Results

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jun 11, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 8, 2024, 2:36 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Apr 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Feb 29, 2024, 11:39 AM EST - 2 years ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 7:55 AM EST - 2 years ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 27, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 15, 2024, 8:30 AM EST - 2 years ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 5, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Jan 9, 2024, 7:55 AM EST - 2 years ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 3, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Nov 8, 2023, 2:43 PM EST - 2 years ago

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Doozio Feb. 21 at 6:41 PM

$VCEL 🐒🍌🧠⏰♾️

0 · Reply

SuperGreenToday Feb. 19 at 6:33 PM

0 · Reply

Groyper69 Feb. 14 at 4:24 AM

$VCEL 👀🤯

0 · Reply

Pro_From_Dover Feb. 12 at 3:04 PM

$VCEL worst stock on a major index. these management fools got nuthin for investors.

0 · Reply

copperhat Feb. 11 at 2:59 PM

$VCEL wtf???

0 · Reply

Pro_From_Dover Feb. 9 at 3:18 PM

$VCEL POS

0 · Reply

copperhat Feb. 9 at 3:02 PM

$VCEL degenerate shit

0 · Reply

copperhat Feb. 6 at 1:43 PM

$VCEL seriously, down $1.50 premarket?

0 · Reply

Pro_From_Dover Feb. 5 at 8:21 PM

$VCEL another day of rockin it, I see.

0 · Reply

copperhat Feb. 5 at 6:52 PM

$VCEL seriously, wtf?

0 · Reply

copperhat Feb. 4 at 5:52 PM

$VCEL sudden influx of bot info regurgitation.

0 · Reply

NFTFlowPro Feb. 4 at 1:35 PM

$VCEL is a regenerative medicine company with approved skin and cartilage products; its growth is steady but faces reimbursement challenges and requires direct salesforce execution.

0 · Reply

Groyper69 Feb. 2 at 7:11 PM

$VCEL let’s get back to $67/sh 😍😍😍🤯🤯🤯

0 · Reply

Pro_From_Dover Jan. 30 at 10:39 PM

$VCEL another week of utter garbage

0 · Reply

copperhat Jan. 30 at 2:53 PM

$VCEL total piece of crap

0 · Reply

copperhat Jan. 28 at 3:46 PM

$VCEL what is wrong with this???

0 · Reply

Pro_From_Dover Jan. 27 at 5:40 PM

$VCEL this is a dog of a company. down close to 4% AGAIN. WTF. pos.

0 · Reply

tm1340 Jan. 27 at 2:18 PM

$VCEL has there been any talk about the heart drug vericel was developing? I know they didn’t get an approval at least 5 years ago and it kind of went by the wayside. Hard to believe if they tried for an approval they would just let it die. For anyone who hasn’t been following this page for at least a decade vericel was trying to get passed a drug to regenerate heart muscle.

2 · Reply

SuperGreenToday Jan. 23 at 9:10 PM

$VCEL Share Price: $37.90 Contract Selected: Jul 17, 2026 $40 Calls Buy Zone: $2.21 – $2.73 Target Zone: $4.13 – $5.04 Potential Upside: 76% ROI Time to Expiration: 174 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Pro_From_Dover Jan. 23 at 6:24 PM

$VCEL -5%… crappy volume. What else is new in the vcel slums?

0 · Reply

copperhat Jan. 21 at 7:48 PM

$VCEL how come it takes off when I sell 37.10!

2 · Reply

copperhat Jan. 21 at 3:34 PM

$VCEL limp turd

0 · Reply

Market Cap	1.93B
Revenue (ttm)	237.22M
Net Income (ttm)	10.36M
EPS (ttm)	N/A
PE Ratio	159.04
Forward PE	63.19
Profit Margin	4.37%
Debt to Equity Ratio	0.00

Volume	157,164
Avg Vol	520,578
Day's Range	N/A - N/A
Shares Out	50.57M
Stochastic %K	84%
Beta	1.24
Analysts	Strong Sell
Price Target	$55.00